FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

7498011000036105: Eligard 1 Month (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg syringe (trade product unit of use)


Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
449951000036110 Eligard 1 Month (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg syringe en Synonym Active Case sensitive Australian Medicines Terminology module
449971000036117 Eligard 1 Month (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg syringe (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Eligard 1 Month (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg syringe Is a trade product unit of use true Inferred relationship Some
Eligard 1 Month (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg syringe Is a Eligard 1 Month true Inferred relationship Some
Eligard 1 Month (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg syringe Is a leuprorelin acetate 7.5 mg modified release injection, syringe true Inferred relationship Some
Eligard 1 Month (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg syringe has intended active ingredient leuprorelin true Inferred relationship Some 1506189052
Eligard 1 Month (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg syringe has unit of use syringe true Inferred relationship Some 1506189053
Eligard 1 Month (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg syringe has Australian BoSS leuprorelin acetate true Inferred relationship Some 1506189052
Eligard 1 Month (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg syringe has manufactured dose form modified release injection true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Bi Eligard CP 1 Month (1 x Eligard 1 Month pack, 28 x Bicalutamide (MPL) tablets), 1 pack has TPUU True Eligard 1 Month (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg syringe Inferred relationship Some 3
Bi Eligard CP 1 Month (1 x Eligard 1 Month pack, 28 x Bicalutamide (MPL) tablets), 1 pack has TPUU True Eligard 1 Month (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg syringe Inferred relationship Some 2
Eligard 1 Month (1 x 7.5 mg syringe, 1 x inert diluent syringe), 1 pack has TPUU True Eligard 1 Month (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg syringe Inferred relationship Some 1
Eligard 1 Month (1 x 7.5 mg syringe, 1 x inert diluent syringe), 1 pack has TPUU True Eligard 1 Month (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg syringe Inferred relationship Some 2
Bi Eligard CP 1 Month (1 x Eligard 1 Month pack, 28 x Bicalutamide (Tolmar) tablets), 1 pack has TPUU True Eligard 1 Month (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg syringe Inferred relationship Some 1
Bi Eligard CP 1 Month (1 x Eligard 1 Month pack, 28 x Bicalutamide (Tolmar) tablets), 1 pack has TPUU True Eligard 1 Month (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg syringe Inferred relationship Some 3

Reference Sets

Trade product unit of use reference set

Back to Start